Repligen (RGEN): William Blair Investment Management, LLC opened a new position $108M
William Blair Investment Management, LLC opened a new position in Repligen, per its Q2 2026 13F.
- 789K
- Shares reported
- 0.32%
- Disclosed portfolio weight
- $108M
- Reported value
- Holdings as of
- Jun 30, 2026
- Filed
- Aug 12, 2026
What stands out in this filing
- A new position in Q2 2026: 788,571 shares, none in the manager's Q1 2026 filing.
- Reported at $108M, 0.32% of the portfolio value in this 13F filing.
- 7 other tracked managers reported the same kind of change for Q2 2026.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 25, 2026InsiderCFO sold ~$106K of RGEN shares in the open market
- Jul 16, 2026InsiderCFO sold ~$80K of RGEN shares in the open market
- Jul 21, 2026Company filing · Form 8-K · Material agreement, ResultsSigned an important agreement, and reported its results (and 2 more items)
- Jul 28, 2026Company filing · Form 8-K · ResultsReported its results
What came next
- Aug 20, 2026InsiderCEO sold ~$977K of RGEN shares in the open market
- Sep 1, 2026Federal contract · $169K obligatedDepartment of Agriculture awarded REPLIGEN CORP: $169K obligated to date
- Sep 4, 2026InsiderCEO sold ~$504K of RGEN shares in the open market
- Sep 10, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 10, 2026, Karen A. Dawes notified Repligen Corporation (“Repligen”) that she will be retiring from the Repligen Board of Directors (the “Board”) after over twenty years of distinguished service to Repligen, effective as of September 30, 2026.”
- Sep 21, 2026InsiderCEO sold ~$977K of RGEN shares in the open market
- Sep 24, 2026Insider · 1 personInsiders: 2 sales (~$2.5M)
- Oct 5, 2026Insider · 1 personInsiders: 2 sales (~$1.0M)
- Oct 6, 2026Company filing · Form 8-K · Acquisition or sale, Reg FDCompleted buying or selling a business or assets, and shared information with investors“The information set forth in the “Explanatory Note” of this Current Report on Form 8-K is incorporated by reference into this”
- Oct 7, 20265% stakeFMR LLC reported a passive stake (13G) of 13.0%
- Oct 27, 2026Company filing · Form 8-K · ResultsReported its results
- Oct 29, 2026Company filing · Form 8-K · Unregistered shares, Other newsSold new shares without registering them, and reported other company news
- Nov 6, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 1 more item)
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Repligen
For Repligen, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RGEN page.
How this filing works
Explore the data
Common questions
What does this filing report about Repligen (RGEN) stock?
William Blair Investment Management, LLC opened a new position in Repligen, per its Q2 2026 13F. 789K shares reported, 0.32% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Jun 30, 2026. Filed: Aug 12, 2026.
What stands out in this filing?
A new position in Q2 2026: 788,571 shares, none in the manager's Q1 2026 filing. Reported at $108M, 0.32% of the portfolio value in this 13F filing. 7 other tracked managers reported the same kind of change for Q2 2026.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Repligen recently?
For Repligen, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days. They are listed on the RGEN page.
Does this mean RGEN stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Repligen
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 4Oct 6, 2026
- SEC Form 4Oct 6, 2026
- SEC Form 144Oct 5, 2026
- SEC Form 144Oct 5, 2026
Everything OQRO holds on this company is on its RGEN page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
